Abstract
IV immunoglobulin therapy can lead to vascular events through increased serum viscosity and possibly other mechanisms. The authors describe the successful use of tissue plasminogen activator in three of four patients who developed cerebral and peripheral arterial thrombosis after treatment with IV immunoglobulin.
MeSH terms
-
Arteries
-
Female
-
Humans
-
Immunoglobulins, Intravenous / adverse effects*
-
Intracranial Thrombosis / drug therapy
-
Intracranial Thrombosis / etiology
-
Male
-
Middle Aged
-
Peripheral Vascular Diseases / drug therapy
-
Peripheral Vascular Diseases / etiology
-
Thrombosis / drug therapy*
-
Thrombosis / etiology*
-
Tissue Plasminogen Activator / therapeutic use*
Substances
-
Immunoglobulins, Intravenous
-
Tissue Plasminogen Activator